- Head of Late-Stage Growth
United States, Institutional
Change
The views expressed are those of the speaker at the time of filming. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
How could Trump 2.0 impact late-stage private companies? Matt Witheiler, head of late-stage growth, explores the potential impact of inflation and tariffs on the late-stage market in 2025.
Expert
Showing
of
Insights Posts
URL References
Related Insights
Read next
Showing
of
Insights Posts
Video
3 min
Deep dive on CLO equity investing
Alyssa Irving, Fixed Income Portfolio Manager, discusses the CLO equity asset class, highlighting its diversification potential, risk-return dynamics, and the crucial role of managers.
3 min
Video
2027-08-31
Article
7 min
What investors should watch as private credit market matures
Private credit is entering a more mature phase, marked by greater selectivity, broader opportunities, deeper market infrastructure, and growing emphasis on manager selection.
7 min
Article
2026-12-31
Article
8 min
AI governance for private companies
Explore the critical need for AI governance for private companies, addressing evolving risks, regulations, and best practices for responsible gen AI usage.
8 min
Article
2027-07-17
Article
5 min
The role of commercial real estate debt in an insurance portfolio
We examine how commercial real estate debt fits within an insurance portfolio, from its diversification and income characteristics to key considerations around regulatory classification, capital treatment, and portfolio construction.
5 min
Article
2028-07-30
Article
5 min
Looking beyond mega-caps
We explore how the growing concentration of capital in mega-cap private companies is reshaping the venture and growth opportunity set, and the implications for portfolio construction, manager selection, diversification, and potential return opportunities across private markets.
5 min
Article
2027-06-30
Article
5 min
IPO readiness through a public and private market lens
Our Value Creation Team brings together portfolio company leaders and Wellington investors to explore key issues shaping private markets, with takeaways from a recent IPO market discussion.
5 min
Article
2027-07-02
8 min
The state of commercial real estate
We explore how macroeconomic, demographic, and sector-specific trends are reshaping commercial real estate, and why selectivity by sector, asset, quality, and capital structure may matter more than broad asset-class exposure.
8 min
2027-06-30
Article
9 min
Preparing for a shift in US exceptionalism
Equity Strategist Andrew Heiskell and Macro Strategist Nicolas Wylenzek explore the evolving nature of US exceptionalism in their 2026 midyear equity outlook.
9 min
Article
2027-07-31
Article
8 min
Private biotech investing deep dive
We explore the distinct characteristics of private biotech investing, including how the asset class differs from traditional venture capital and how clinical milestones, specialized underwriting, and portfolio construction shape its risk, return, and diversification potential.
8 min
Article
2028-05-31
Article
4 min
The IPO market inflection
Our late-stage private market experts explore how a small cohort of scaled, AI-driven IPOs could reshape distributions, public-market structure, and exit decisions across the venture ecosystem.
4 min
Article
2027-05-31
Article
8 min
The convergence of public and private markets – a three-part full-picture perspective
In part one of our new series on public and private market convergence, we explore how companies and issuers are navigating a broader set of capital tools across equity and debt, reshaping funding, liquidity, and financing strategy.
8 min
Article
2028-06-01
URL References
Related Insights